Ouro Medicines Selects THREAD as Clinical Technology Partner to Enable Digital Monitoring in their Clinical Trials
Collaboration Adds THREAD’s Technology and Enablement Services Focused on Reducing Patient Clinic Visitations with Innovative Remote Monitoring Solution
CARY, N.C., 07 OCT 2025 – Since its initial launch in 2018, THREAD’s no-code SaaS research platform and consulting services have been focused on innovating technology implementation and endpoint data capture to enable clinical research for everyone, everywhere. Today, the company announces its support of Ouro Medicines’ clinical trials for OM336 in which THREAD’s technology platform orchestrates a remote monitoring solution that allows participants to spend more time at home, and less time in the clinic.
“One of our core patient-centricity objectives in this trial design was to reduce the number of days participants needed to be in the clinic while maintaining robust monitoring protocols,” said Sarah Maddux, VP of Clinical Operations at Ouro Medicines. “The THREAD team was able to implement a fit-for-purpose technology solution that made this a possibility.”
The implementation of the THREAD platform in clinical trials for OM336 includes an integrated wearable device that passes vital sign and other data to THREAD’s platform where data are surfaced to research site staff through reporting dashboards that allow site staff to monitor participants remotely. Site staff are trained on THREAD’s telehealth feature to allow for seamless, rapid virtual interaction with participants to assess the need for in-person visits based on customized alerts. The THREAD platform is also being leveraged by a home health provider performing in-person assessments for source data capture.
"We are grateful to be selected by and partner with Ouro Medicines to support clinical trials for OM336,” said John Reites, Co-founder and CEO at THREAD. “Enabling this innovative and patient-focused trial design is exactly why we exist as a company as we seek to make research available to everyone, everywhere.”
Learn more about THREAD’s partnership with Ouro Medicines, see a demo of our digital health solutions, and explore how we support sponsors to remove legacy systems, reduce costs and remove risks in deploying their research studies: https://discover.threadresearch.com/schedule-demo.
##
About THREAD
THREAD’s® purpose is to leverage its clinical research platform to enable studies for everyone, everywhere. The companies’ uniquely combined clinical research technology and consulting services help life science organizations to design, operate, and scale next-generation research studies and electronic clinical outcome assessments (eCOA) programs for participants, sites, and study teams. Through its comprehensive platform and scientific expertise, THREAD empowers studies to be accessible, efficient, and centered on the patient. THREAD is recognized as a leader by Everest Group’s Decentralized Clinical Trial Product PEAK Matrix® Assessment 2021/2022/2023 and positioned in the Leader's Category of the 2022 IDC MarketScape for R&D Decentralized Clinical Trial Technology Solutions Vendor Assessment 2022. Visit THREADresearch.com to learn more.
Media Contact
Les Yates
THREAD
media@THREADresearch.com